L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating

The L&G Gerd Kommer Multifactor Equity ETF is most frequently paired with broad market trackers like SPYI, which provides a comprehensive global equity base. In portfolios where GERD serves as a core holding, it is often combined with these market-cap-weighted funds in roughly 60/40 splits to balance factor-tilted performance with traditional beta. This combination allows investors to maintain a global footprint while tilting toward value, size, and quality factors, effectively smoothing out the volatility inherent in pure multifactor strategies.

EuroFolio users primarily utilize GERD as either a concentrated, all-in-one equity solution or as a strategic satellite to enhance factor exposure within a broader portfolio. The data shows that high-performing portfolios holding 100 percent GERD achieve consistent returns near 15.5 percent with moderate volatility, suggesting that investors view it as a sufficient standalone vehicle for long-term growth. When used as a smaller component, such as the 7 percent allocation seen in the Trajan 2 portfolio, it functions as a tactical tilt alongside individual stocks and money market instruments, indicating that users trust the fund to provide sophisticated factor exposure without requiring complex manual rebalancing.